[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2056983T3 - Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa. - Google Patents

Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.

Info

Publication number
ES2056983T3
ES2056983T3 ES89104251T ES89104251T ES2056983T3 ES 2056983 T3 ES2056983 T3 ES 2056983T3 ES 89104251 T ES89104251 T ES 89104251T ES 89104251 T ES89104251 T ES 89104251T ES 2056983 T3 ES2056983 T3 ES 2056983T3
Authority
ES
Spain
Prior art keywords
inhibit
lipoxigenase
biosynthesis
metabolites
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89104251T
Other languages
English (en)
Inventor
Edward S Lazer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharmaceuticals Inc filed Critical BOEHRINGER INGELHEIM PHARMA
Application granted granted Critical
Publication of ES2056983T3 publication Critical patent/ES2056983T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/373—Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • C07C45/565—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA INHIBEN 5 - LIPOOXIGENADO Y SE USAN EN EL TRATAMIENTO DE LA INFLAMACION.
ES89104251T 1988-03-21 1989-03-10 Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa. Expired - Lifetime ES2056983T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17051288A 1988-03-21 1988-03-21

Publications (1)

Publication Number Publication Date
ES2056983T3 true ES2056983T3 (es) 1994-10-16

Family

ID=22620151

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89104251T Expired - Lifetime ES2056983T3 (es) 1988-03-21 1989-03-10 Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.

Country Status (16)

Country Link
EP (1) EP0334119B1 (es)
JP (1) JPH024729A (es)
KR (1) KR890014514A (es)
AU (1) AU628324B2 (es)
DD (1) DD283602A5 (es)
DE (1) DE68907095T2 (es)
DK (1) DK134489A (es)
ES (1) ES2056983T3 (es)
FI (1) FI891295A (es)
HU (2) HU207858B (es)
IL (1) IL89666A0 (es)
NO (1) NO169648C (es)
NZ (1) NZ228410A (es)
PH (1) PH26928A (es)
PT (1) PT90066B (es)
ZA (1) ZA892086B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626955A1 (en) * 1992-02-11 1994-12-07 Allergan, Inc. Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity
ATE135697T1 (de) * 1992-10-28 1996-04-15 Shionogi & Co Benzylidenderivate
ES2087019B1 (es) * 1994-02-08 1997-03-16 Bobel246 S L Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la 5-lipoxigenasa.
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
US6376524B1 (en) * 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
KR100836207B1 (ko) 2001-01-18 2008-06-09 웰리켐 바이오 테크 인크. 면역 질환 치료용의 신규한 1,2-디페닐에텐 유도체
JP4425628B2 (ja) 2001-07-23 2010-03-03 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 細胞保護化合物、薬学的処方物および美容用処方物、ならびに方法
EP2520290B1 (en) * 2003-12-23 2014-12-10 Abraxis BioScience, LLC Propofol analogs, process for their preparation, and methods of use
WO2006078941A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Novel sirtuin activating compounds and methods of use thereof
BR112020009158A2 (pt) 2017-11-10 2020-10-27 Dermavant Sciences GmbH processo para o preparo de um composto, composto e composição farmacêutica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3188315A (en) * 1960-05-18 1965-06-08 Schering Corp Novel compounds for lowering blood cholesterol levels
FR1390978A (fr) * 1963-11-20 1965-03-05 Ind Chimique Sa Procédé de préparation de l'alpha-(thiényl-2) 4-hydroxystilbène et de quelques dérivés et produits obtenus
US4758586A (en) * 1985-02-01 1988-07-19 Usv Pharmaceutical Corp. Indolyl compounds and hyposensitivity use thereof
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung
US4743606A (en) * 1986-03-25 1988-05-10 Boehringer Ingelheim Pharmaceuticals, Inc. 3-[2-(3',5'-di-t-butyl-4'-hydroxyphenyl)ethenyl]pyridine having anti-inflammatory and anti-arthritic properties
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
CA1338645C (en) * 1987-01-06 1996-10-15 George R. Pettit Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins"

Also Published As

Publication number Publication date
AU3151489A (en) 1989-09-21
NO891114D0 (no) 1989-03-15
EP0334119A1 (en) 1989-09-27
DK134489A (da) 1989-09-22
HU207858B (en) 1993-06-28
KR890014514A (ko) 1989-10-24
DD283602A5 (de) 1990-10-17
HU9201174D0 (en) 1992-07-28
NO169648B (no) 1992-04-13
IL89666A0 (en) 1989-09-28
EP0334119B1 (en) 1993-06-16
PT90066A (pt) 1989-11-10
PT90066B (pt) 1994-05-31
NO169648C (no) 1992-07-22
PH26928A (en) 1992-12-03
JPH024729A (ja) 1990-01-09
DE68907095D1 (de) 1993-07-22
NZ228410A (en) 1993-08-26
NO891114L (no) 1989-09-22
HUT50093A (en) 1989-12-28
AU628324B2 (en) 1992-09-17
FI891295A0 (fi) 1989-03-20
DK134489D0 (da) 1989-03-20
ZA892086B (en) 1990-11-28
FI891295A (fi) 1989-09-22
DE68907095T2 (de) 1994-01-05

Similar Documents

Publication Publication Date Title
BG46598A3 (en) Method for preparation of alpha- heterocyclic substituted tolunitriles
FI860914A (fi) Fenylkarbamater.
ES8708127A1 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
PT956282E (pt) Derivados de acido sulfinico e sua preparacao e utilizacao
NO942994D0 (no) Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
ES2040208T3 (es) Pirazolinas insecticidas.
DK324286A (da) 1-substituerede oxindol-3-carboxamider og deres anvendelse som antiinflammatoriske og analgetiske midler
MY109722A (en) Azaoxindole derivatives.
ES2056983T3 (es) Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.
IT1156745B (it) Farmaci contenenti composti sterolici 15-ossigenati e procedimento per impedire la biosintesi di acido mevalonico
BG104726A (en) Novel derivatives of the dihydroxyhexanoic acid
IT1074295B (it) Procedimento per la preparazione di derivati dell acido fusidico particolarmente utili come batteri cidi
FI950842A (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
DK321888D0 (da) Anvendelse af jordalkalisalte af ethercarboxylsyr er som katalysatorer til alkoxylering
ES2097423T3 (es) Analogos de vitamina d3.
GB2324528A (en) Cytostatic hydroxamic acid derivatives
IT1114284B (it) Procedimento per mantenere attiva la cultura di fermenti
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
FR2395998A1 (fr) Nouveaux derives de la thiazolidine et leur application dans le traitement de l'hypertension
DE3785689D1 (de) Verwendung von prostaglandin-biosynthese-hemmer.
IT1227456B (it) Nuovi alcossi derivati di ginkgolidi, loro preparazione e composizioni terapeutiche che li contengono
FR2443460A1 (fr) Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs
AU4994585A (en) Pesticidal biphenylyloxy and biphenylylalkoxy aryl acyl urea compounds
ES2090806T3 (es) Acilsulfonamido- y sulfonamido-piridina-2-esteres de acidos carboxilicos, asi como sus piridina-n-oxidos, procedimientos para su preparacion y su utilizacion como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 334119

Country of ref document: ES